Compare AOSL & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOSL | PRCT |
|---|---|---|
| Founded | 2000 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 919.1M | 1.0B |
| IPO Year | 2007 | 2021 |
| Metric | AOSL | PRCT |
|---|---|---|
| Price | $32.06 | $18.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $24.00 | ★ $35.44 |
| AVG Volume (30 Days) | 634.0K | ★ 1.5M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $342,291,000.00 | $308,054,000.00 |
| Revenue This Year | N/A | $31.34 |
| Revenue Next Year | $6.41 | $24.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $17.01 | $16.67 |
| 52 Week High | $54.34 | $51.18 |
| Indicator | AOSL | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 43.47 | 38.11 |
| Support Level | $19.24 | $16.67 |
| Resistance Level | $46.93 | $29.27 |
| Average True Range (ATR) | 2.52 | 1.04 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 47.71 | 30.60 |
Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries. It operates in one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.